Tandem mass spectrometry adds fragment-level evidence to a research peptide mass match.

Tandem mass spectrometry adds fragment-level evidence to a research peptide mass match. Those fragments can support an amino-acid sequence, while precursor mass alone narrows the possible candidates.

A neutral peptide mass is the peptide's mass without an added charge. A mass match narrows the possible sequences, since different amino-acid chains can have the same or very similar mass.
A mass spectrometer measures mass-to-charge ratio, written as m/z, rather than neutral mass. The charge state, meaning the number of charges carried by an ion, lets researchers work back from m/z to neutral mass.
For example, an ion with two charges has an m/z value close to half its neutral mass, with a small contribution from the added protons. The instrument reports the charged ion's m/z, so the charge state must be known to compare it with a neutral peptide mass.
At about 2,000 Da and 1 ppm accuracy, a mass matches an average of 4 unmodified tryptic peptides in the human proteome and 1.5 in the yeast proteome, according to published research. A tryptic peptide is a protein fragment produced when the enzyme trypsin cuts a protein at certain sites. One ppm means one part per million of the measured mass.
At around 2000 Da and 1 ppm accuracy, a mass matches 4 human and 1.5 yeast unmodified tryptic peptides on average.
These averages show why even a precise mass match is evidence for a candidate, not proof of a unique sequence. A mass by itself does not reveal the order of amino acids that produced it.
Tandem mass spectrometry, also called MS/MS, selects one precursor ion for further study. A precursor ion is the charged peptide chosen from the sample before it is broken apart.

The instrument then breaks the selected ion into product ions, which are smaller charged pieces. Collision-induced dissociation is a common method: the instrument makes the peptide ion collide with gas, and the impact can break its backbone.
The precursor's m/z and charge state help researchers estimate its neutral mass. The product ions then provide more detailed evidence than that mass alone because their sizes reflect parts of the peptide chain.
Not every possible fragment appears in a spectrum. The peptide's charge state, its sequence, and the collision energy all affect which pieces form and which are strong enough to detect.
As a result, a missing peak does not automatically rule out a sequence. Researchers compare the pattern that appears with the expected fragments under the conditions used to make them.
A peptide backbone is the linked chain of amino acids. When it breaks at different points, fragments can retain either end of that chain.
b ions retain the peptide's N-terminal end, while y ions retain its C-terminal end. In each series, the next fragment usually adds one amino acid's mass, so a run of matching peaks can support the order of residues.
For example, a b-ion series can show how the chain grows from one end. A y-ion series provides a second view from the other end, which can help check whether the proposed sequence fits both patterns.
Sequence support depends on linked fragments across several positions, not one matching peak. A single peak may fit many possible fragments, while a connected series provides stronger evidence for a specific order.
Some expected ions may be weak or absent because of the peptide's structure or the fragmentation conditions. The full pattern, including both b and y ions where available, matters more than an isolated match.
A database search compares peaks in the measured spectrum with fragments predicted from known peptide sequences. A peptide-spectrum match, or PSM, is a proposed link between one measured spectrum and one peptide sequence.

A PSM score ranks how well the observed peaks fit the predicted fragments. A high score means a closer fit under that search method, but the score alone does not prove that the sequence is correct.
Search tools may also use de novo sequencing. This method builds a possible sequence from the fragment pattern without first matching it to a known sequence list.
MS-based proteomics uses mass spectrometry to study proteins by measuring the peptides they produce. A database search can connect peptide evidence to known proteins, while de novo sequencing can help when a sequence is absent from the searched list.
Both approaches depend on the quality of the spectrum and the assumptions used to read it. A database search can only find candidates included in its sequence list, while de novo results can remain uncertain where fragments are missing or ambiguous.
Prefer a sequence assignment supported by several linked b and y ions across the peptide. Check whether the fragments cover more than one part of the chain, rather than relying on one strong peak or a score alone.
Search settings should fit the sample and the way it was prepared. Enzyme rules define expected cut sites, charge settings describe the ion states allowed in the search, and modification settings allow for known chemical changes.
If the settings allow only the expected enzyme cuts, a peptide with a missed cut may not appear as a candidate. Likewise, a search that excludes a likely modification may fail to match a shifted peptide.
Decoy-based error estimates compare real sequence matches with deliberately false matches. The gap between those groups helps estimate how often accepted matches may be wrong; this is an estimated error rate, not a guarantee about any one PSM.
Repeated, consistent matches across separate spectra add support for a sequence. Even so, a peptide may occur in more than one protein, so its match alone may not identify the parent protein.
Leucine and isoleucine have the same mass. Ordinary mass measurements and many routine fragment patterns may not tell them apart, leaving two sequences with the same measured mass and similar fragment evidence.

Specialized side-chain fragmentation methods or independent sequence evidence may help resolve that ambiguity. For near-isobaric sequences, accurate precursor and fragment measurements can help distinguish them when their masses differ enough to measure.
A post-translational modification is a chemical change made to a protein after it is produced. Such a change can shift a peptide's mass, and fragments on both sides of the changed residue can help locate where it occurred.
Fragments that do not include the changed site may keep their expected mass. Fragments that include it may carry the shift, which helps narrow the modification's position along the sequence.
Missed enzyme cuts create longer peptides than expected. A search that allows only the usual cut pattern may overlook those longer forms, even when their spectra contain useful sequence evidence.
Precursor selection can also affect the result. If the instrument selects overlapping precursor ions, fragments from more than one peptide may enter the same spectrum and make the sequence pattern harder to interpret.
Finally, one peptide can be shared by several proteins. Identifying its sequence does not establish which protein supplied it, so protein identification needs other supporting evidence.
MS/MS adds evidence about amino-acid order by measuring fragments from a selected peptide ion. Linked b and y ions can support a sequence more directly than precursor mass alone.
A confident assignment also depends on suitable search settings, an informative fragment pattern, and a realistic estimate of match errors. Even then, sequence identification and parent-protein identification remain separate conclusions.